To evaluate the potential clinical relevance of our findings, the presence of M2 macrophages (CD163+ CD206+) was determined in BM samples from MM patients, and compared with samples from patients with smoldering myeloma (SM), monoclonal gammopathy of undetermined significance (MGUS) and healthy volunteers. This evidence concerns the gene CD163 and smoldering plasma cell myeloma.